1,056
Views
45
CrossRef citations to date
0
Altmetric

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Giacomo Casabona, Olivia Berton, Tina Singh, Markus Knuf & Paolo Bonanni. (2023) Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context. Expert Review of Vaccines 22:1, pages 764-776.
Read now
Nicola P. Klein, Ousseny Zerbo, Kristin Goddard, Weiqi Wang, Alison E. Fohner, Amy Wiesner, Vida Shokoohi, John Coller, Karin Bok & Hayley A. Gans. (2021) Genetic associations with a fever after measles-containing vaccines. Human Vaccines & Immunotherapeutics 17:6, pages 1763-1769.
Read now
Paolo Bonanni, Sara Boccalini, Angela Bechini, Ornella Varone, Giulio Matteo, Federica Sandri & Giovanni Gabutti. (2020) Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines. Human Vaccines & Immunotherapeutics 16:6, pages 1313-1321.
Read now
Ousseny Zerbo, Sharareh Modaressi, Kristin Goddard, Edwin Lewis, Karin Bok, Hayley Gans & Nicola P. Klein. (2020) Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines. Human Vaccines & Immunotherapeutics 16:4, pages 875-880.
Read now
Norberto Giglio, Homero Monsanto, Emmanouil Rampakakis, H. Keri Yang, Barbara J. Kuter & Lara J. Wolfson. (2018) Economic burden of varicella in children 1–12 years of age in Argentina, 2009–2014. Journal of Medical Economics 21:4, pages 416-424.
Read now

Articles from other publishers (40)

Maria A. Nagel, Anne A. Gershon, Ravi Mahalingam, Christy S. Niemeyer & Andrew N. Bubak. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1215 1250.e17 .
William J. Moss & Peter M. Strebel. 2023. Plotkin's Vaccines. Plotkin's Vaccines 629 663.e19 .
Miad Boodaghidizaji, Shreya Milind Athalye, Sukirt Thakur, Ehsan Esmaili, Mohit S. Verma & Arezoo M. Ardekani. (2022) Characterizing viral samples using machine learning for Raman and absorption spectroscopy. MicrobiologyOpen 11:6.
Crossref
Elena Bozzola, Stefano Guolo, Giulia Macchiarulo, Lidia Festa, Giulia Spina, Andrzej Krzysztofiak, Annalisa Grandin, Mauro Bozzola, Massimiliano Raponi & Alberto Villani. (2020) Hospitalization for acute cerebellitis in children affected by varicella: how much does it cost?. Italian Journal of Pediatrics 46:1.
Crossref
Carlo Giaquinto, Giovanni Gabutti, Vincenzo Baldo, Marco Villa, Lara Tramontan, Nadia Raccanello, Francesca Russo, Chiara Poma, Antonio Scamarcia, Luigi Cantarutti, Rebecca Lundin, Emilia Perinetti, Xavier Cornen, Stéphane Thomas, Céline Ballandras, Audrey Souverain & Susanne Hartwig. (2018) Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy. BMC Infectious Diseases 18:1.
Crossref
S. Carazo Perez, A. Bureau & G. De Serres. (2018) Post-immunisation fever and the antibody response to measles-containing vaccines. Epidemiology and Infection 146:12, pages 1584-1592.
Crossref
Anne A. Gershon, Mona Marin & Jane F. Seward. 2018. Plotkin's Vaccines. Plotkin's Vaccines 1145 1180.e17 .
Peter M. Strebel, Mark J. Papania, Paul A. Gastañaduy & James L. Goodson. 2018. Plotkin's Vaccines. Plotkin's Vaccines 579 618.e21 .
Nicola P. Klein, Edwin Lewis, Julia McDonald, Bruce Fireman, Allison Naleway, Jason Glanz, Lisa A. Jackson, James G. Donahue, Steven J. Jacobsen, Eric Weintraub & Roger Baxter. (2017) Risk factors and familial clustering for fever 7–10 days after the first dose of measles vaccines. Vaccine 35:12, pages 1615-1621.
Crossref
Lili Wang, Lucy Zhu & Hua Zhu. (2016) Efficacy of varicella (VZV) vaccination: an update for the clinician. Therapeutic Advances in Vaccines 4:1-2, pages 20-31.
Crossref
Shu-Juan Ma, Xing Li, Yi-Quan Xiong, A.-.ling Yao & Qing Chen. (2015) Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children. Medicine 94:44, pages e1721.
Crossref
Shu-Juan Ma, Yi-Quan Xiong, Li-Na Jiang & Qing Chen. (2015) Risk of febrile seizure after measles–mumps–rubella–varicella vaccine: A systematic review and meta-analysis. Vaccine 33:31, pages 3636-3649.
Crossref
Lesley J. Scott. (2015) Measles–Mumps–Rubella–Varicella Combination Vaccine (ProQuad®): A Guide to Its Use in Children in the EU. Pediatric Drugs 17:2, pages 167-174.
Crossref
Nicola P. KleinEdwin LewisBruce FiremanSimon J. HambidgeAllison NalewayJennifer C. NelsonEdward A. BelongiaW. Katherine YihJames D. NordinRulin C. Hechter, Eric Weintraub & Roger Baxter. (2015) Safety of Measles-Containing Vaccines in 1-Year-Old Children. Pediatrics 135:2, pages e321-e329.
Crossref
Stephanie O. Klopfer, Jon E. Stek, Maria Petrecz, Keith S. Reisinger, Steven B. Black, Michelle G. Goveia, Ouzama Nicholson, Julie L. Gardner, Anthony D. Grosso, Michelle L. Brown, Barbara J. Kuter & Florian P. Schödel. (2014) Analysis of safety data in children after receiving two doses of ProQuad® (MMRV). Vaccine 32:52, pages 7154-7160.
Crossref
Kristine Macartney, Anita Heywood & Peter McIntyre. (2014) Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews.
Crossref
Simon J. HambidgeSophia R. NewcomerKomal J. NarwaneyJason M. GlanzMatthew F. DaleyStan XuJo Ann ShoupAli Rowhani-RahbarNicola P. KleinGrace M. LeeJennifer C. NelsonMarlene LuggAllison L. NalewayJames D. Nordin, Eric Weintraub & Frank DeStefano. (2014) Timely Versus Delayed Early Childhood Vaccination and Seizures. Pediatrics 133:6, pages e1492-e1499.
Crossref
P. Carrillo-Santisteve & P.L. Lopalco. (2014) Varicella vaccination: a laboured take-off. Clinical Microbiology and Infection 20, pages 86-91.
Crossref
Tania Schink, Jakob Holstiege, Frank Kowalzik, Fred Zepp & Edeltraut Garbe. (2014) Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine 32:6, pages 645-650.
Crossref
D. Mentzer, H. Meyer & B. Keller-Stanislawski. (2013) Sicherheit und Vertr?glichkeit von monovalenten Masern- und kombinierten Masern-, Mumps-, R?teln- und VarizellenimpfstoffenSafety and tolerability of monovalent measles and combined measles, mumps, rubella, and varicella vaccines. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:9, pages 1253-1259.
Crossref
Anne A. Gershon, Michiaki Takahashi & Jane F. Seward. 2013. Vaccines. Vaccines 837 869 .
Peter M. Strebel, Mark J. Papania, Amy Parker Fiebelkorn & Neal A. Halsey. 2013. Vaccines. Vaccines 352 387 .
Gabriela Rüger, Giovanni Gabutti, Hans Rümke, Lars Rombo, Enrique Bernaola, Javier Diez-Domingo, Federico Martinon-Torres, Birthe Høgh, Antreas Konstantopoulos, Anne Fiquet, Stéphane Thomas, Cécile Eymin & Martine Baudin. (2012) Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin. Pediatric Infectious Disease Journal 31:11, pages 1166-1172.
Crossref
Adele Visser & Anwar Hoosen. (2012) Combination vaccines in the South African setting. Vaccine 30, pages C38-C44.
Crossref
Mark M. Blatter, Nicola P. Klein, Julie S. Shepard, Michael Leonardi, Steven Shapiro, Martin Schear, Maurice A. Mufson, Judith M. Martin, Meera Varman, Stanley Grogg, Arnold London, Pierre Cambron, Martine Douha, Ouzama Nicholson, Christopher da Costa & Bruce L. Innis. (2012) Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children Twelve to Fourteen Months of Age. Pediatric Infectious Disease Journal 31:8, pages e133-e140.
Crossref
Timo Vesikari, Thomas Becker, Vincent Gajdos, Anne Fiquet, Stéphane Thomas, Patrick Richard & Martine Baudin. (2012) Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age. Vaccine 30:20, pages 3082-3089.
Crossref
Markus Knuf, Fred Zepp, Klaus Helm, Hartwig Maurer, Albrecht Prieler, Dorothee Kieninger-Baum, Martine Douha & Paul Willems. (2011) Antibody persistence for 3 years following two doses of tetravalent measles–mumps–rubella–varicella vaccine in healthy children. European Journal of Pediatrics 171:3, pages 463-470.
Crossref
Michael LeonardiKenneth BrombergRoger BaxterJulie L. GardnerStephanie KlopferOuzama NicholsonMichael Brockley, James Trammel, Vicky Leamy, Wendy WilliamsBarbara KuterFlorian Schödel. (2011) Immunogenicity and Safety of MMRV and PCV-7 Administered Concomitantly in Healthy Children. Pediatrics 128:6, pages e1387-e1394.
Crossref
Markus Knuf, Fred Zepp, Claudius U. Meyer, Pirmin Habermehl, Lothar Maurer, Hanns-Michael Burow, Ulrich Behre, Michel Janssens, Paul Willems, Helmtrud Bisanz, Volker Vetter & Ruprecht Schmidt-Ott. (2010) Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles–mumps–rubella–varicella vaccine to children aged 11–21 months. European Journal of Pediatrics 169:8, pages 925-933.
Crossref
Timo Vesikari, Aino Karvonen, Niklas Lindblad, Tiina Korhonen, Patricia Lommel, Paul Willems, Ilse Dieussaert & Lode Schuerman. (2010) Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months. Pediatric Infectious Disease Journal 29:6, pages e47-e56.
Crossref
Paolo Bonanni, Judith Breuer, Anne Gershon, Michael Gershon, Waleria Hryniewicz, Vana Papaevangelou, Bernard Rentier, Hans Rümke, Catherine Sadzot-Delvaux, Jacques Senterre, Catherine Weil-Olivier & Peter Wutzler. (2009) Varicella vaccination in Europe – taking the practical approach. BMC Medicine 7:1.
Crossref
Steven J. Jacobsen, Bradley K. Ackerson, Lina S. Sy, Trung N. Tran, Tonia L. Jones, Janis F. Yao, Fagen Xie, T. Craig Cheetham & Patricia Saddier. (2009) Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 27:34, pages 4656-4661.
Crossref
Sonali K. Sanghavi, David T. Rowe & Charles R. Rinaldo. 2009. Clinical Virology Manual. Clinical Virology Manual 454 493 .
Sueli L. Tillieux, Wendy S. Halsey, Ganesh M. Sathe & Ventzislav Vassilev. (2009) Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra™ and ProQuad™ live attenuated combined vaccines. Vaccine 27:16, pages 2265-2273.
Crossref
Y. Gillet, G.C. Steri, U. Behre, J.P. Ars?ne, X. Lanse, K. Helm, S. Esposito, N. Meister, M.G. Desole, M. Douha & P. Willems. (2009) Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months?2 years or 2?6 years primed with measles-mumps-rubella (MMR) vaccine. Vaccine 27:3, pages 446-453.
Crossref
Penelope H. Dennehy, Jenifer L. Jaeger, Phyllis T. Losikoff & David L. Pugatch. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases 3340 3400 .
Sueli L. Tillieux, Wendy S. Halsey, Elizabeth S. Thomas, John J. Voycik, Ganesh M. Sathe & Ventzislav Vassilev. (2008) Complete DNA Sequences of Two Oka Strain Varicella-Zoster Virus Genomes. Journal of Virology 82:22, pages 11023-11044.
Crossref
Volker Schuster, Walter Otto, Lothar Maurer, Patricia Tcherepnine, Ulrich Pfletschinger, Klaus Kindler, Peter Soemantri, Uta Walther, Ute Macholdt, Martine Douha, Patrice Pierson & Paul Willems. (2008) Immunogenicity and Safety Assessments After One and Two Doses of a Refrigerator-Stable Tetravalent Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children During the Second Year of Life. Pediatric Infectious Disease Journal 27:8, pages 724-730.
Crossref
Kristine Macartney & Peter McIntyre. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Barbara Kuter & Florian Schodel. (2007) Second Varicella Vaccine Dose. The Pediatric Infectious Disease Journal 26:2, pages 193-194.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.